Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R286798-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $62.90 | |
R286798-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $99.90 | |
R286798-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $204.90 | |
R286798-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $327.90 | |
R286798-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $523.90 |
Nrf2 activator; inhibits Nrf2/Keap1 interaction
Synonyms | (3S)-1-[4-[[(2,3,5,6-Tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-3-pyrrolidinecarboxylic acid |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Mechanism of action | kelch like ECH-associated protein 1 |
Product Description | Product description RA839 is a noncovalent small molecule binder to Keap1 with a Kd of ∼6 μM and selective activator of Nrf2 signaling. RA839 prevents the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages. RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compound to study the biology of Nrf2. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (3S)-1-[4-[(2,3,5,6-tetramethylphenyl)sulfonylamino]naphthalen-1-yl]pyrrolidine-3-carboxylic acid |
---|---|
INCHI | InChI=1S/C25H28N2O4S/c1-15-13-16(2)18(4)24(17(15)3)32(30,31)26-22-9-10-23(21-8-6-5-7-20(21)22)27-12-11-19(14-27)25(28)29/h5-10,13,19,26H,11-12,14H2,1-4H3,(H,28,29)/t19-/m0/s1 |
InChi Key | BVYWIQHJXAEJOD-IBGZPJMESA-N |
Canonical SMILES | CC1=CC(=C(C(=C1C)S(=O)(=O)NC2=CC=C(C3=CC=CC=C32)N4CCC(C4)C(=O)O)C)C |
Isomeric SMILES | CC1=CC(=C(C(=C1C)S(=O)(=O)NC2=CC=C(C3=CC=CC=C32)N4CC[C@@H](C4)C(=O)O)C)C |
PubChem CID | 91971266 |
Molecular Weight | 452.57 |
PubChem CID | 91971266 |
---|---|
RCSB PDB Ligand | 51M |
CAS Registry No. | 1832713-02-6 |
BindingDB Ligand | 50200467 |
ChEMBL Ligand | CHEMBL3899754 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2427267 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427268 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427269 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427270 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427271 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427272 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427273 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427274 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427275 | Certificate of Analysis | Jan 20, 2024 | R286798 |
B2427276 | Certificate of Analysis | Jan 20, 2024 | R286798 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 45.26, Max Conc. mM: 100 |
---|---|
Sensitivity | light sensitive |
1. Winkel AF, Engel CK, Margerie D, Kannt A, Szillat H, Glombik H, Kallus C, Ruf S, Güssregen S, Riedel J et al.. (2015) Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.. J Biol Chem, 290 (47): (28446-55). [PMID:26459563] |
2. Patra U, Mukhopadhyay U, Sarkar R, Mukherjee A, Chawla-Sarkar M. (2019) RA-839, a selective agonist of Nrf2/ARE pathway, exerts potent anti-rotaviral efficacy in vitro.. Antiviral Res, 161 (3): (53-62). [PMID:30465784] |